期刊文献+

Foxp3^+淋巴细胞在乳腺癌组织中的表达及临床意义 被引量:1

Expression of Foxp3^+ lymphocytes in breast carcinoma tissues and their clinic significance
原文传递
导出
摘要 目的探讨Foxp3+淋巴细胞在人乳腺癌组织中的表达及其与其他临床病理因素的关系,并对其可能作用机制进行探讨。方法采用流式细胞术(FCM)检测30例乳腺癌患者肿瘤组织及癌旁正常组织中Foxp3+淋巴细胞百分率,并采用多元线性回归分析法统计分析肿瘤组织中Foxp3+淋巴细胞表达与患者临床病理学特征的相互关系;免疫组化法检测肿瘤组织及癌旁正常组织中浸润淋巴细胞中TGF-β和IL-10表达情况,并采用直线相关分析法统计分析其与Foxp3+淋巴细胞表达的相关性。结果肿瘤组织中Foxp3+淋巴细胞百分率明显高于癌旁正常组织(P<0.05),同时肿瘤组织中Foxp3+淋巴细胞百分率与临床分期、有无脉管瘤栓、腋淋巴结转移等临床病理因素有关(P<0.05)。肿瘤组织浸润淋巴细胞的IL-10表达与肿瘤组织中Foxp3+淋巴细胞百分率正相关(P<0.05)。结论Foxp3+淋巴细胞与乳腺癌侵袭转移有关,其机制与其分泌IL-10抑制机体抗肿瘤免疫有关。Foxp3+淋巴细胞可作为乳腺癌预后判断的辅助指标,也有望成为乳腺癌临床治疗的新标靶。 Objective To investigate the expression of Foxp3+ lymphocytes in breast carcinoma tissues and their correlation with other pathological factors,and to investigate the mechanism of action of Treg cells.Methods The expression of Foxp3+ lymphocytes in the breast cancer tissue and non-cancerous tissue was detected by flow cytometry (FCM) in 30 breast carcinoma patients,and its correlation with other pathological factors was statistically analyzed by multiple linear regression analysis.The expression of TGF-β and IL-10 in the lymphocytes infiltrated in breast cancer tissue and non-cancerous tissue was measured by immunohistochemistry,and their correlation with the expression of Foxp3+ lymphocytes was statistically analyzed by linear correlation dependability analysis.Results There was significant difference in the expression of Foxp3+ lymphocytes between the malignant and non-cancerous breast tissues(P0.05),and it was positively correlated with the clinical stage,blood vessel invasion and the matter of axillary lymph node metastasis(P0.05).The expression of IL-10 in the tumor infiltrating lymphocytes was positively correlated with the expression of Foxp3+ lymphocytes(P0.05).Conclusion The expression level of Foxp3+ lymphocytes is correlated with invasion and metastasis of breast carcinoma,and the IL-10 secreted by Foxp3+ lymphocytes may be involved in this effect.Foxp3+ lymphocytes can be used as an assistant marker for prediction and new therpeutic target of breast cancer.
出处 《军事医学科学院院刊》 CSCD 北大核心 2010年第1期61-64,67,共5页 Bulletin of the Academy of Military Medical Sciences
基金 河北普通高等学校强势特色学科建设课题项目
关键词 乳腺肿瘤 Foxp^3+淋巴细胞 流式细胞术 脉管瘤栓 肿瘤转移 breast neoplasms Foxp3+ lymphocytes flow cytometry blood vessel invasion neoplasm metastasis
  • 相关文献

参考文献16

  • 1Williams LM,Rudensky AY.Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3[J].Nat Immunol,2007,8(3):277-284. 被引量:1
  • 2Wan YY,Flavell RA.Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression[J].Nature,2007,445(7129):766-770. 被引量:1
  • 3李喆.CD4^+CD25^+调节性T细胞核调控基因FOXP3与移植物抗宿主病的关系[D/OL].南宁:广西医科大学,2008.http://dlib.cnki.net/kns50/detail.aspx?QueryID=3&CurRec=3. 被引量:1
  • 4Schabowsky RH,Madireddi S,Sharma R,et al.Targeting CD4^+CD25^+Foxp3^+ regulatory T-cells for the augmentation of cancer immunotherapy[J].Curr Opin Invest Drugs,2007,8(12):1002-1008. 被引量:1
  • 5Yang ZZ,Novak AJ,Stenson MJ,et al.Intratumoral CD4^+CD25^+ regulatory T-cell-mediated suppression of infiltrating CD4~+ T cells in B-cell non-Hodgkin lymphoma[J].Blood,2006,107(9):3639-3646. 被引量:1
  • 6Elpek KG,Lacelle C,Singh NP,et al.CD4^+CD25^+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model[J].J Immunol,2007,178(11):6840-6848. 被引量:1
  • 7Yang XH,Yamagiwa S,Ichida T,et al.Increase of CD4^+CD25^+ regulatory T-cells in the liver of patients with hepatocellular carcinoma[J].J Hepatol,2006,45(2):254-262. 被引量:1
  • 8Curiel TJ,Coukos G,Zou L,et al.Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival[J].Nat Med,2004,10(9):942-949. 被引量:1
  • 9Leffers N,Gooden MJ,de Jong RA,et al.Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer[J].Cancer Immunol Immunother,2009,58(3):449-459. 被引量:1
  • 10Ebert LM,Tan BS,Browning J,et al.The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells[J].Cancer Res,2008,68:3001-3009. 被引量:1

二级参考文献29

  • 1Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO [J]. Trends Immunol, 2003,24 (5) : 242-248. 被引量:1
  • 2Uyttenhove C, Pilotte L, Theate I, el al. Evidence for a tumoral immune resistance mechanism based tryptophan degradation by indoleamine 2,3-dioxygenase [J].Nat Med, 2003,9(10) : 1269-1274. 被引量:1
  • 3Astigiano S, Morandi B, Costa R, et al. Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer [J]. Neoplasia, 2005,7(4) : 390-396. 被引量:1
  • 4Okamoto A, Nikaido T, Ochiai K, et al. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells [J]. Clin Cancer Res, 2005, 11 (16) : 6030-6039. 被引量:1
  • 5Ino K, Yoshida N, Kajiyama H, et al. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer [ J ]. Br J Cancer, 2006,95 ( 11 ) : 1555-1561. 被引量:1
  • 6Brandacher G, Perathoner A, Ladurner R, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in coloreetal cancer: effect on tumor-infiltrating T cells [J]. Clin Cancer Res, 2006, 12 (4) : 1144-1151. 被引量:1
  • 7Pan K, Wang H, Chen MS, et al. Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma [J]. J Cancer Res Clin Oncol, 2008,134( 11 ) : 1247- 1253. 被引量:1
  • 8Bauer TM, Jiga LP, Chuang JJ, et al. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo [J]. Transpl Int, 2005,18 ( 1 ) :95-100. 被引量:1
  • 9Munn DH,Mellor AL. Indoleamine 2, 3-dioxygenase and tumor-induced tolerance [J]. J Clin Invest, 2007, 117(5): 1147-1154. 被引量:1
  • 10Munn DH, Sharma MD, Hou D, et al. Expression of indoleamine 2,3- dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes [J]. J Clin Invest, 2004,114 (2): 280-290. 被引量:1

共引文献12

同被引文献14

  • 1甘长清,王小毅.CD4^+CD25^+调节性T细胞和Foxp3在不同病理类型乳腺癌患者外周血和组织中表达水平及其临床意义[J].免疫学杂志,2009,25(3):322-325. 被引量:9
  • 2Beyer M,Schultze JL.Regulatory T cells in cancer [J].Blood 2006,108(3):804-811. 被引量:1
  • 3Hartigan-O' ConnorD J, Poon C, Sinclair E, et al. Human CD4 (+) regulatory T cells express lower levels of the IL-7 receptor alpha chain ( CD127 ), allowing consistent identification and sorting of live cells [J]. J Immunol Methods, 2007,319(1): 41-52. 被引量:1
  • 4Tanaka H,Tanaka J,Kjaergaard J,et al. Depletion of CD4^+CD25^+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes[J].Immunother,2002,25 (3) : 207-217. 被引量:1
  • 5Sakaguchi S, Sakaguchi N, Asano M, et al . Immunologic seK-tolerance maintained by activated T cells expressing IL-2 receptor alpha 2 chains ( CD25 ) : breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995,155(3): 1151-1164. 被引量:1
  • 6Hori S,Nomura T, Sakaguchi S. Control of regulatory T cells development by the transcription factor Foxp3 [J] . Science, 2003, 299 (56) :1057-1061. 被引量:1
  • 7Morgan ME ,van Bilsen JH ,Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4^+CD25^+T regulatory cells in humans[J]. Hum Immunol, 2005,66 (1) :13-20. 被引量:1
  • 8Seddiki N,Santner-Nanan B,Martinson J,et al. Expressionof interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells[J]. J Exp bled, 2006, 203(7): 1693-1700. 被引量:1
  • 9Shimizu J,Yamazaki S,Sakaguchi S.Induction of tumor immunity by removing CD25^+CD4^+ cells: a common basis between tumor immunity and autoimmunity[J].J Immunol,1999, 163 (10):5211-5218. 被引量:1
  • 10Wolf AM, Wolf D, Steure rM, et al. Increase in regulatory T cells in the peripheral blood of cancer patients [J].Clin Cancer Res, 2003, 9(2): 606-612. 被引量:1

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部